Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Taysha Gene Therapies (TSHA) Interest Coverage Ratio (2022 - 2025)

Taysha Gene Therapies' Interest Coverage Ratio history spans 4 years, with the latest figure at 2268.27 for Q3 2025.

  • For Q3 2025, Interest Coverage Ratio fell 110.2% year-over-year to 2268.27; the TTM value through Sep 2025 reached 1399.04, down 1163.99%, while the annual FY2024 figure was 896.66, 6086.57% down from the prior year.
  • Interest Coverage Ratio for Q3 2025 was 2268.27 at Taysha Gene Therapies, down from 1573.71 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 10.1 in Q3 2022 and bottomed at 2268.27 in Q3 2025.
  • The 4-year median for Interest Coverage Ratio is 73.89 (2022), against an average of 587.61.
  • The largest annual shift saw Interest Coverage Ratio surged 83.69% in 2023 before it plummeted 9668.19% in 2024.
  • A 4-year view of Interest Coverage Ratio shows it stood at 41.35 in 2022, then soared by 44.9% to 22.79 in 2023, then plummeted by 3876.23% to 906.0 in 2024, then plummeted by 150.36% to 2268.27 in 2025.
  • Per Business Quant, the three most recent readings for TSHA's Interest Coverage Ratio are 2268.27 (Q3 2025), 1573.71 (Q2 2025), and 1127.42 (Q1 2025).